NMR Relaxometry for Biopharmaceutical Aggregation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting biopharmaceutical aggregation are destructive, time-consuming, and not suitable for high-throughput quality checks, making it difficult to assess the degradation of pharmaceutical preparations nondestructively and efficiently.
Innovation Solution
The use of NMR relaxation rates (R1 and R2) of water molecules as indicators of biopharmaceutical aggregation, allowing for nondestructive measurement of aggregation and detection of counterfeit compositions through magnetic resonance relaxometry, utilizing commercially available benchtop NMR and MRI instruments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional techniques (SEC, AUC-SV, DLS, electrophoresis) are used to detect aggregation, then measurement precision is improved, but productivity deteriorates due to time-consuming procedures and destructive sampling
Solution Approach 1:
The patent replaces mechanical/chemical separation techniques (SEC, AUC-SV, DLS) with magnetic resonance relaxometry, a physical measurement method that detects aggregation through changes in water relaxation rates. This substitution enables nondestructive, rapid measurement without sample preparation or complex instrumentation, thereby improving both productivity and maintaining measurement precision.
Solution Approach 2:
The invention utilizes the water already present in the biopharmaceutical formulation as the NMR probe, eliminating the need for external tracers or labels. The water molecules naturally interact with aggregated proteins, providing self-contained detection that simplifies the measurement process and enables high-throughput screening.
2Measurement precision
If conventional techniques are used to assess degradation, then measurement precision is improved, but loss of time increases due to destructive sampling requiring vial opening
Solution Approach 1:
The patent replaces destructive mechanical opening and sample handling with nondestructive magnetic resonance measurement. The relaxometry technique penetrates the vial wall and directly measures the magnetic properties of water molecules in the formulation, eliminating time-consuming sample preparation while maintaining accurate degradation assessment.
Solution Approach 2:
The invention uses water molecules as an intermediary probe that mediates between the aggregation state of proteins and the NMR detection system. Water relaxation rates change in response to protein aggregation, providing indirect but accurate measurement of degradation without direct contact or destruction of the sample.
3Productivity
If NMR relaxation rates are used to detect aggregation, then productivity is improved through fast nondestructive measurement, but device complexity increases due to requirement of NMR instrumentation
Solution Approach 1:
The patent employs benchtop NMR relaxometers that are relatively inexpensive, compact, and designed for routine quality control applications rather than research-grade spectroscopy. These simplified instruments provide sufficient measurement capability for aggregation detection while being cost-effective and easy to operate in manufacturing environments.
Solution Approach 2:
The invention extracts only the essential measurement capability needed for aggregation detection from full NMR spectroscopy systems. By focusing solely on relaxation rate measurements (T1 and T2) rather than complete spectral analysis, the method uses simplified instrumentation that maintains productivity benefits while reducing device complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables fast, reliable, and nondestructive assessment of biopharmaceutical aggregation and detection of counterfeits, ensuring product usability and quality control without opening the vial, using universally applicable NMR relaxation rates that are sensitive to aggregation and composition variations.
Implementation Method 1
NMR relaxation rates (R1 and R2) of water molecules as indicators of biopharmaceutical aggregation, allowing for nondestructive measurement of aggregation and detection of counterfeit compositions through magnetic resonance relaxometry
Data Source
AI summary
The present invention generally relates to a method of using NMR relaxation rates (R2) of water molecules as an indicator of the extent of aggregation of biopharmaceutical formulations. The biopharmaceutical can be evaluated nondestructively without the vial or container being opened or protective seal compromised (i.e., broken). The method is applicable to all biopharmaceuticals and the water signal obtained by magnetic resonance relaxometry is very strong and sensitive because water is used as the solvent and is present in high (>90%) concentrations in every biopharmaceutical formulation.